Cytokinetics (CYTK) News Today $35.51 -1.84 (-4.93%) As of 10:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CYTK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period 7,500 Shares in Cytokinetics, Incorporated $CYTK Purchased by Carlson Capital L.P.2 hours ago | marketbeat.comComerica Bank Increases Position in Cytokinetics, Incorporated $CYTK5 hours ago | marketbeat.comNorthern Trust Corp Has $58.17 Million Stock Position in Cytokinetics, Incorporated $CYTKAugust 29 at 3:56 AM | marketbeat.comCW Advisors LLC Takes $1.13 Million Position in Cytokinetics, Incorporated $CYTKAugust 28 at 5:07 AM | marketbeat.comPrice T Rowe Associates Inc. MD Sells 631,185 Shares of Cytokinetics, Incorporated $CYTKAugust 28 at 5:06 AM | marketbeat.comCytokinetics to Participate in September Investor ConferencesAugust 27 at 4:00 PM | globenewswire.comCytokinetics, Incorporated $CYTK Shares Acquired by Capital Fund Management S.A.August 27 at 4:49 AM | marketbeat.comCytokinetics to Present Positive Aficamten Results at ESC Congress 2025 with Investor Webcast Scheduled for September 2, 2025August 25, 2025 | quiverquant.comQCytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025August 25, 2025 | globenewswire.comCandriam S.C.A. Sells 25,579 Shares of Cytokinetics, Incorporated $CYTKAugust 24, 2025 | marketbeat.com351,368 Shares in Cytokinetics, Incorporated $CYTK Bought by Nuveen LLCAugust 24, 2025 | marketbeat.comInvesco Ltd. Has $20.17 Million Stock Position in Cytokinetics, Incorporated $CYTKAugust 24, 2025 | marketbeat.comCytokinetics, Incorporated $CYTK Stake Lessened by T. Rowe Price Investment Management Inc.August 23, 2025 | marketbeat.comRep. Lisa C. McClain Sells Cytokinetics, Incorporated (NASDAQ:CYTK) SharesAugust 23, 2025 | marketbeat.comCytokinetics (NASDAQ:CYTK) EVP Sells $76,620.00 in StockAugust 21, 2025 | marketbeat.comCytokinetics, Incorporated $CYTK Shares Bought by Algert Global LLCAugust 21, 2025 | marketbeat.comCytokinetics: Specialty Franchise With Aficamten And UlacamtenAugust 20, 2025 | seekingalpha.comCytokinetics Names Jim Daly to Board of DirectorsAugust 20, 2025 | globenewswire.comCytokinetics, Incorporated $CYTK Shares Bought by Aberdeen Group plcAugust 20, 2025 | marketbeat.comCytokinetics Inc (CYTK) Announces Stock Options and RSUs for New Employees | CYTK stock newsAugust 19, 2025 | gurufocus.comInsider Sell: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK)August 19, 2025 | gurufocus.comCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 19, 2025 | globenewswire.comFox Run Management L.L.C. Acquires New Stake in Cytokinetics, Incorporated (NASDAQ:CYTK)August 18, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Reduces Stake in Cytokinetics, Incorporated (NASDAQ:CYTK)August 18, 2025 | marketbeat.comFY2025 EPS Estimates for Cytokinetics Decreased by AnalystAugust 17, 2025 | marketbeat.comCytokinetics, Incorporated (NASDAQ:CYTK) Shares Sold by Vanguard Group Inc.August 16, 2025 | marketbeat.comCytokinetics, Incorporated (NASDAQ:CYTK) Given Consensus Recommendation of "Moderate Buy" by AnalystsAugust 16, 2025 | marketbeat.comCytokinetics’ Aficamten Study: A Potential Breakthrough for Pediatric Heart HealthAugust 14, 2025 | msn.comCiti Lowers Cytokinetics (CYTK) PT to $77 Due to Uneventful Q2 2025 EarningsAugust 14, 2025 | msn.comFMR LLC's Strategic Acquisition of Cytokinetics Inc SharesAugust 14, 2025 | gurufocus.comCytokinetics (NASDAQ:CYTK) Issues Earnings Results, Beats Expectations By $0.22 EPSAugust 11, 2025 | marketbeat.comCytokinetics (NASDAQ:CYTK) Upgraded by Wall Street Zen to "Hold" RatingAugust 11, 2025 | marketbeat.comCytokinetics (NASDAQ:CYTK) Price Target Lowered to $77.00 at CitigroupAugust 10, 2025 | marketbeat.comNatixis Advisors LLC Purchases 11,806 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)August 10, 2025 | marketbeat.comCytokinetics, Incorporated (CYTK) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comCytokinetics price target lowered to $77 from $80 at CitiAugust 8, 2025 | msn.comCytokinetics Reports Q2 2025 Financial Results and UpdatesAugust 8, 2025 | msn.comCytokinetics shares rise on strong Q2 resultsAugust 8, 2025 | in.investing.comCYTK Earnings Jump 3,065%August 8, 2025 | theglobeandmail.comCytokinetics Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 7, 2025 | globenewswire.comCM Management LLC Buys Shares of 40,000 Cytokinetics, Incorporated (NASDAQ:CYTK)August 7, 2025 | marketbeat.comInsider Selling: Cytokinetics, Incorporated (NASDAQ:CYTK) EVP Sells 2,000 Shares of StockAugust 6, 2025 | marketbeat.comInsider Sell Alert: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK)August 6, 2025 | gurufocus.comWestfield Capital Management Co. LP Acquires 30,346 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)August 6, 2025 | marketbeat.comJ. Safra Sarasin Holding AG Buys 14,764 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)August 4, 2025 | marketbeat.comPacer Advisors Inc. Sells 16,503 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)August 3, 2025 | marketbeat.comCytokinetics (CYTK) Expected to Announce Quarterly Earnings on ThursdayAugust 1, 2025 | marketbeat.comCytokinetics to Present New Aficamten Data at ESC Congress 2025August 1, 2025 | msn.comCytokinetics (NASDAQ:CYTK) Coverage Initiated at Raymond James FinancialJuly 31, 2025 | marketbeat.comRaymond James downgrades Cytokinetics (CYTK) to a HoldJuly 31, 2025 | theglobeandmail.com Get Cytokinetics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYTK Media Mentions By Week CYTK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYTK News Sentiment▼1.461.03▲Average Medical News Sentiment CYTK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYTK Articles This Week▼1310▲CYTK Articles Average Week Get the Latest News and Ratings for CYTK and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cytokinetics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Genmab A/S News Viatris News Dr. Reddy's Laboratories News Ascendis Pharma A/S News Qiagen News Moderna News Verona Pharma PLC American Depositary Share News BridgeBio Pharma News Elanco Animal Health News Roivant Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYTK) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access